首页 | 本学科首页   官方微博 | 高级检索  
     


Selective enrichment in human megakaryocyte progenitors by the B203.13 surface differentiation antigen
Authors:Marco,Vitale ,Giorgio,Zauli ,Alessandra,Bassini ,Giuseppe,Visani ,Rita,Rezzani ,Carlo M.,Croce &   Francesco Antonio, Manzoli
Affiliation:Department of Biomedical Sciences and Biotechnology, Human Anatomy Section, Brescia,;Institute of Human Anatomy, University of Ferrara, Ferrara,;Institute of Haematology,;Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, U.S.A.,;Institute of Human Anatomy, University of Bologna, Bologna, Italy
Abstract:The B203.13 monoclonal antibody specifically recognizes a subset (8–18.5%) of human CD34+ haemopoietic progenitors, which are significantly ( P  < 0.05) enriched in megakaryocyte progenitors (CFU-meg). Moreover, B203.13 expression was progressively lost as maturation proceeded along the megakaryocytic lineage. In fact: (i) CFU-meg derived from CD34+/B203.13+ showed a greater number of cells/colony with respect to CD34+/B203.13; (ii) after 10 d of liquid cultures with 100 ng/ml of thrombopoietin, only a minority of CD34-derived cells positive for CD41 coexpressed B203.13; (iii) in situ immunocytochemical staining revealed that B203.13 was expressed exclusively on immature megakaryoblasts; (iv) circulating platelets did not express B203.13.
Keywords:megakaryocytes    platelets    cell differentiation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号